CalciMedica Regains Nasdaq Minimum Bid Price Compliance After 10 Days Above $1.00
CalciMedica received a Nasdaq letter on September 15, 2026 confirming it has regained compliance with the minimum bid price rule, after its closing bid stayed at $1.00 or greater for 10 consecutive business days from August 31 to September 14, 2026. The company has no outstanding Nasdaq deficiency notices, which removes the risk of delisting over the bid price issue for shareholders.
Key points
- Nasdaq notice of non-compliance dated March 16, 2026, after the bid price was below $1.00 for 30 consecutive business days
- Compliance deadline was September 14, 2026, 180 calendar days after the notice
- Nasdaq letter received September 15, 2026 confirmed compliance with Listing Rule 5550(a)(2)
- Company reports no outstanding Nasdaq deficiency notices as of the filing date
The filing
Written by AI on Nov 9, 2026, 8:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 16, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.